Savara Inc (SVRA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.02B
Last updated: Nov 17, 2026 at 11:05 AM ET
Savara Inc (SVRA) Competitors
The companies most similar to Savara are Innoviva (INVA), Theravance Biopharma (TBPH) and Inventiva Sa (IVA). By market cap, Savara ranks 7th of the 13 companies on this page; Maravai Lifesciences Holdings (MRVI) is the largest at $1.96B.
Peer Comparison
SVRA's ROIC of -87.3% is below the peer median of -65.0%, and its revenue growth of 0.0% is above the median of -0.8%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Savara (SVRA) | $1.02B | N/A | N/A | 0.0% | -87.3% | 0.0% | 0.00% |
| Innoviva Inc (INVA) | $1.35B | 5.3x | 3.0x | 44.1% | 10.8% | -1.6% | 0.00% |
| Theravance Biopharma Inc (TBPH) | $884.18M | 95.1x | 8.4x | 51.6% | N/A | -20.9% | 0.00% |
| Inventiva Sa (IVA) | $879.90M | N/A | 133.4x | 0.0% | -327.7% | -76.7% | 0.00% |
| Maravai Lifesciences Holdings Inc (MRVI) | $1.96B | N/A | 5.2x | -30.8% | -28.3% | 10.1% | 0.00% |
| Corvus Pharmaceuticals Inc (CRVS) | $897.52M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Sellas Life Sciences Group Inc (SLS) | $1.60B | N/A | N/A | 0.0% | N/A | -82.5% | 0.00% |
| Syndax Pharmaceuticals Inc (SNDX) | $850.77M | N/A | 2.8x | -72.3% | -65.0% | 81.6% | 0.00% |
| Verastem Inc (VSTM) | $1.03B | N/A | 7.8x | -178.4% | -110.4% | 113.6% | 0.00% |
| Solid Biosciences LLC (SLDB) | $763.42M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Jade Biosciences, Inc. (JBIO) | $1.03B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Oric Pharmaceuticals Inc (ORIC) | $814.71M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| CureVac NV (CVAC) | $1.05B | N/A | 1.8x | 182.1% | N/A | -89.0% | 0.00% |
| Peer median | $961.99M | 50.2x | 5.2x | 0.0% | -65.0% | -0.8% | 0.00% |
Similar Companies
These are the 12 companies most similar to Savara, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Innoviva Inc (INVA) | Innoviva, Inc. is dedicated to the development and commercialization of pharmaceutical products. The company is headquartered in Burlingame, California. | INVA competitors |
| Theravance Biopharma Inc (TBPH) | Theravance Biopharma, Inc., a diversified biopharmaceutical company, discovers, develops, and markets organ-selective drugs in the United States, Europe... | |
| Inventiva Sa (IVA) | Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic... | |
| Maravai Lifesciences Holdings Inc (MRVI) | Maravai LifeSciences Holdings, Inc., a life sciences company, offers products to enable the development of drug therapies, diagnostics, novel vaccines... | MRVI competitors |
| Corvus Pharmaceuticals Inc (CRVS) | Corvus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. | CRVS competitors |
| Sellas Life Sciences Group Inc (SLS) | SELLAS Life Sciences Group, Inc., an advanced-stage biopharmaceutical company, focuses on the development of new cancer immunotherapies for various indications... | SLS competitors |
| Syndax Pharmaceuticals Inc (SNDX) | Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. | SNDX competitors |
| Verastem Inc (VSTM) | Verastem, Inc., a developing-stage biopharmaceutical company focused on developing and commercializing life-enhancing drugs for cancer patients. | VSTM competitors |
| Solid Biosciences LLC (SLDB) | Solid Biosciences Inc., a life sciences company, is dedicated to developing therapies for Duchenne muscular dystrophy (DMD) in the United States. | SLDB competitors |
| Jade Biosciences, Inc. (JBIO) | Jade Biosciences, Inc. is a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune... | JBIO competitors |
| Oric Pharmaceuticals Inc (ORIC) | ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of cancers. | ORIC competitors |
| CureVac NV (CVAC) | CureVac NV, a clinical-stage biopharmaceutical company, is focused on developing various transformative drugs based on messenger ribonucleic acid (mRNA). |
Frequently Asked Questions About SVRA
Who are Savara's main competitors?
The companies most similar to Savara include Innoviva (INVA), Theravance Biopharma (TBPH), Inventiva Sa (IVA), Maravai Lifesciences Holdings (MRVI) and Corvus Pharmaceuticals (CRVS), listed from the closest match.
Who is Savara's biggest competitor?
Maravai Lifesciences Holdings (MRVI) is the largest of the similar companies at $1.96B; Innoviva (INVA) is the closest match by business profile, size, sector and industry.
How does SVRA stock compare with its competitors?
SVRA's net margin is 0.0% against a peer median of 0.0%.
Which of Savara's competitors pays a higher dividend?
Savara pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Savara bigger than its competitors?
No. Savara is 7th by market cap among the 13 companies on this page; the largest is Maravai Lifesciences Holdings (MRVI) at $1.96B.
SVRA pages: Overview, Earnings, Forecast, Financials, Competitors